François Ducray

Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas

Marc Sanson, Yannick Marie, Sophie Paris et al. · Journal of Clinical Oncology · 2009 · 993 citations · Full text

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal et al. · New England Journal of Medicine · 2023 · 606 citations · Full text

Characteristics of H3 K27M-mutant gliomas in adults

David Meyronet, Maud Esteban-Mader, Charlotte Bonnet et al. · Neuro-Oncology · 2016 · 287 citations · Full text

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas

Romain Appay, Caroline Dehais, Claude‐Alain Maurage et al. · Neuro-Oncology · 2019 · 276 citations · Full text

Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis

Aurélien Viaccoz, Virginie Desestret, François Ducray et al. · Neurology · 2014 · 229 citations